Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-06ADPT144Chad Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Chad Robins filed Form 144 to notify SEC of plan to sell 83332 units of Adaptive Biotechnologies Corporation securities around 2026-04-06, with aggregate market value of $1,173,314.56. The total outstanding units is 153981561.0. The amount planned to be sold represents 0.05% of total outstanding units; Recent transacti...
Mid CapBiotechnology
2026-04-06AVTX144MITTIE DOYLE plan to sell securities of AVALO THERAPEUTICS INC under Form 144MEDIUM
MITTIE DOYLE filed Form 144 to notify SEC of plan to sell 65800 units of AVALO THERAPEUTICS INC securities around 2026-04-06, with aggregate market value of $1,168,608.00. The total outstanding units is 22788452.0. The amount planned to be sold represents 0.29% of total outstanding units; Recent transactions in past 3 ...
Small CapBiotechnology
2026-04-06CTNM144DANIEL LORRAIN plan to sell securities of CONTINEUM THERAPEUTIC INC under Form 144MEDIUM
DANIEL LORRAIN filed Form 144 to notify SEC of plan to sell 914 units of CONTINEUM THERAPEUTIC INC securities around 2026-04-06, with aggregate market value of $12,284.16. The total outstanding units is 32673536.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 ...
Small CapBiotechnology